A comprehensive view of Vaccination / Immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
Published:
April 25, 2024
by Sanofi SA
|
GlobalData: Success of mRNA vaccine technology during Covid-19 pandemic could lead to using platform to reduce preventable illness across multiple disease areas; about 507 preventive vaccines in late-stage development, with 88 using mRNA technology
Published:
April 24, 2024
by Indo-Asian News Service
|
Pfizer Canada and McMaster University partner to address health equity gaps in vaccine development and delivery; Pfizer invests C$500,000 into McMaster's Global Nexus for training scholars from underrepresented groups in vaccinology
Published:
April 23, 2024
by PR Web
|
Moderna brings Pfizer/BioNTech to court in London claiming patent breach over COVID-19 vaccine technology; Pfizer and BioNTech deny the allegations and call for two Moderna patents to be declared invalid
Published:
April 23, 2024
by AFP World News
|
Moderna signs contract with Brazil's Ministry of Health to supply 12.5 million doses of its mRNA COVID-19 vaccine for the 2024 national vaccination campaign; vaccine delivery expected in Q2 2024
Published:
April 22, 2024
by Moderna Inc.
|
Ask us about our Tissue & Hygiene market view